Overview

Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies

Status:
Withdrawn

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

This clinical study is designed to evaluate the safety and efficacy of oral administration of the food additive colostrum derived antibodies to Clostridium difficile for prevention of Clostridium difficile associated disease (CDAD).

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Hadassah Medical Organization

Treatments:

Antibodies
Immunoglobulins